Pfizer Inc
NYSE: PFE
$24.99
-$0.11 (-0.4%)
Real Time Data Delayed 15 Min.
PFE Articles
According to Reuters, UBS (UBS) will write-off $3.4 billion, another victim of the credit crunch. Reuters writes that the Teamsters and UPS (UPS) have come to a new contract. Reuters writes that...
Published:
A Canadian court ruled that Apotex could not market a generic version of Viagra, Pfizer’s (PFE) massively successful ED drug. Oddly, Pfizer’s shares were down 1.2% to $24.35. The Big Pharma...
Published:
Patients who swtich from Pfizer’s (PFE) monster selling drug cholesterol pill Lipitor to Merck’s (MRK) Zocor, now available in generic form are more likely to have a heart attack or die....
Published:
According to Reuters, Bush will outline a plan to help holders of sub-prime mortgages. Reuters writes that Dell (DELL) topped Wall St. estimates but sees costs drops slowing. Reuters writees that...
Published:
A new medical study shows that people who take statins, cholesterol-lowering drugs, appear to be less likely to develope Alzheimer’s, one of the most damaging and fastest growing diseases....
Published:
Biopharmaceutical company Xoma (XOMA) is having its luck day. After its stock traded down as low as $2.24, its shares are up almost 20% today on news that it bacterial cell expression technology to...
Published:
According to Reuters, Bear Stearns (BSC) has several potential buyers including JP Morgan (JPM) and Bank of America (BAC) Reuters writes that a court overturned a patent infringement award won by...
Published:
Pfizer (PFE) has FDA approval for a new drug that "blocks the CCR5 co-receptor that serves as a main doorway for the HIV virus into immune cells." It will be marketed as Selzentry and is the first...
Published:
Below are key short interest statistics for July. The figures are as of July 13 compared to June 15, 2007 Largest Short Positions Company ...
Published:
(ABT) Abbott Labs $0.69 EPS vs $0.68 estimate; guidance looks soft.(ASD) American Standard $0.84 EPS net, but $1.05 before items; estimates were $1.08. Spin-off/sale remains on track. (BLK) Blackrock...
Published:
Not a good quarter for Pfizer (PFE). Second quarter revenue fell 6% to $11.1 billion. Net income was down 48% to $1.3 billion. The loss of U.S. exclusivity for Zoloft and Norvasc hurt earnings as did...
Published:
MONDAYMattel (NYSE:MAT)Novellus (NASDAQ:NVLS)Philips Electronics (NYSE:PHG/ADR)W.W. Grainger (NYSE:GWW) TUESDAYJohnson & Johnson (NYSE:JNJ)Intel Corporation (NASDAQ: INTC)Merrill Lynch...
Published:
As you will see, the short interest changes in medical and drug stocks of the active NYSE-listed names was a bit of a mixed bag. GlaxoSmithkline (GSK) saw the lagest increase, but its short...
Published:
Stock Tickers: AA, AIG, AXP, BA, C, CAT, DD, DIS, GE, GM, HD, HON, HPQ, IBK, JNJ, JPM, KO, MCD, MMM, MRK, MO, MRK, PFE, PG, T, UTX, VZ, WMT, XOM As you will see, the June short interest in the 28 of...
Published:
According to Reuters, the IPO for Blackstone priced at the high end of its range, raising $4.13 billion. Reuters writes that GE (GE) and Pearson (PSO) have dropped their potential bid for Dow Jones...
Published: